Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Hoffmann-La Roche
ViroMissile, Inc.
Pfizer
Tizona Therapeutics, Inc
M.D. Anderson Cancer Center
Adaptimmune
Daiichi Sankyo
Second Life Therapeutics
Onchilles Pharma Inc
Novartis
The Netherlands Cancer Institute
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Tempus AI
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
British Columbia Cancer Agency
Memgen, Inc.
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Incyte Corporation
MacroGenics
Milton S. Hershey Medical Center
Providence Health & Services
Marengo Therapeutics, Inc.
Genentech, Inc.
University of California, San Diego
UNICANCER
University of Colorado, Denver
DEKA Biosciences
Rapa Therapeutics LLC
Columbia University
Thomas Jefferson University
Revolution Medicines, Inc.
University Medical Center Groningen
Cedars-Sinai Medical Center
Algemeen Ziekenhuis Maria Middelares
Checkpoint Therapeutics, Inc.
BioAtla, Inc.
Aminex Therapeutics, Inc.
Inhibrx Biosciences, Inc
Novartis
European Organisation for Research and Treatment of Cancer - EORTC
Xencor, Inc.
iTeos Therapeutics
Cedars-Sinai Medical Center
Innolake Biopharm
Presage Biosciences